 Tamas Seres
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography, Transesophageal | 10 | 2019 | 126 | 2.010 |
Why?
| | Echocardiography, Three-Dimensional | 4 | 2012 | 68 | 1.060 |
Why?
| | Tidal Volume | 2 | 2015 | 101 | 0.870 |
Why?
| | Heart Ventricles | 3 | 2018 | 741 | 0.730 |
Why?
| | Lung Injury | 2 | 2015 | 225 | 0.730 |
Why?
| | Heart Neoplasms | 2 | 2012 | 56 | 0.710 |
Why?
| | Heart Transplantation | 4 | 2019 | 706 | 0.700 |
Why?
| | Vena Cava, Inferior | 2 | 2019 | 73 | 0.660 |
Why?
| | Cardiac Surgical Procedures | 4 | 2014 | 561 | 0.650 |
Why?
| | Heart Atria | 2 | 2019 | 138 | 0.640 |
Why?
| | Respiration, Artificial | 2 | 2015 | 667 | 0.640 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 158 | 0.570 |
Why?
| | Septal Occluder Device | 1 | 2018 | 32 | 0.550 |
Why?
| | Tachycardia, Ventricular | 1 | 2018 | 170 | 0.490 |
Why?
| | Cardiopulmonary Bypass | 2 | 2019 | 215 | 0.450 |
Why?
| | Cardiac Catheterization | 1 | 2018 | 525 | 0.440 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2017 | 445 | 0.430 |
Why?
| | Catheter Ablation | 1 | 2018 | 332 | 0.430 |
Why?
| | Cardiac Output | 1 | 2014 | 179 | 0.420 |
Why?
| | Pericarditis, Constrictive | 1 | 2012 | 5 | 0.400 |
Why?
| | MAP Kinase Kinase Kinase 5 | 1 | 2012 | 7 | 0.390 |
Why?
| | Platelet Function Tests | 1 | 2012 | 28 | 0.380 |
Why?
| | Oncogene Proteins | 1 | 2012 | 58 | 0.380 |
Why?
| | Warm Ischemia | 1 | 2011 | 14 | 0.370 |
Why?
| | Sarcoma, Endometrial Stromal | 1 | 2011 | 7 | 0.360 |
Why?
| | Mitral Valve Insufficiency | 1 | 2012 | 71 | 0.360 |
Why?
| | Myocardium | 2 | 2017 | 922 | 0.360 |
Why?
| | Algorithms | 3 | 2014 | 1718 | 0.360 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2012 | 280 | 0.350 |
Why?
| | Cold Ischemia | 1 | 2011 | 32 | 0.350 |
Why?
| | Thrombelastography | 1 | 2012 | 154 | 0.350 |
Why?
| | PTEN Phosphohydrolase | 1 | 2012 | 164 | 0.350 |
Why?
| | Myocardial Ischemia | 1 | 2012 | 278 | 0.340 |
Why?
| | Calcinosis | 1 | 2012 | 238 | 0.340 |
Why?
| | Echocardiography | 1 | 2012 | 638 | 0.310 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2012 | 331 | 0.310 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 463 | 0.310 |
Why?
| | Mitosporic Fungi | 1 | 2009 | 7 | 0.300 |
Why?
| | Surgery, Computer-Assisted | 1 | 2009 | 75 | 0.300 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2011 | 236 | 0.290 |
Why?
| | Blood Platelets | 1 | 2012 | 426 | 0.290 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2009 | 119 | 0.290 |
Why?
| | Heart Failure | 3 | 2015 | 2057 | 0.290 |
Why?
| | Mycoses | 1 | 2009 | 82 | 0.280 |
Why?
| | Pulmonary Valve | 1 | 2009 | 91 | 0.280 |
Why?
| | Prosthesis-Related Infections | 1 | 2009 | 99 | 0.270 |
Why?
| | Thrombosis | 1 | 2011 | 378 | 0.270 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2009 | 177 | 0.270 |
Why?
| | Aortic Valve Stenosis | 1 | 2009 | 239 | 0.250 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2009 | 361 | 0.240 |
Why?
| | Intraoperative Complications | 2 | 2018 | 146 | 0.240 |
Why?
| | Cardiomyopathies | 1 | 2009 | 324 | 0.230 |
Why?
| | Intraoperative Period | 2 | 2014 | 67 | 0.200 |
Why?
| | Heart-Assist Devices | 1 | 2009 | 550 | 0.190 |
Why?
| | Computer Systems | 3 | 2012 | 51 | 0.190 |
Why?
| | Male | 15 | 2019 | 68216 | 0.190 |
Why?
| | Aged | 8 | 2018 | 24182 | 0.190 |
Why?
| | Humans | 21 | 2019 | 138651 | 0.170 |
Why?
| | Middle Aged | 9 | 2019 | 33792 | 0.160 |
Why?
| | Signal Transduction | 1 | 2012 | 5091 | 0.150 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 241 | 0.140 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2017 | 30 | 0.130 |
Why?
| | Cyclophilins | 1 | 2017 | 40 | 0.130 |
Why?
| | Coronary Vasospasm | 1 | 2016 | 8 | 0.130 |
Why?
| | Pilot Projects | 2 | 2012 | 1757 | 0.130 |
Why?
| | Amiodarone | 1 | 2016 | 27 | 0.120 |
Why?
| | Lung Transplantation | 1 | 2019 | 330 | 0.120 |
Why?
| | Liver Transplantation | 2 | 2015 | 861 | 0.120 |
Why?
| | Tropheryma | 1 | 2014 | 7 | 0.110 |
Why?
| | Whipple Disease | 1 | 2014 | 8 | 0.110 |
Why?
| | MAP Kinase Signaling System | 1 | 2017 | 323 | 0.110 |
Why?
| | Uteroglobin | 1 | 2014 | 24 | 0.110 |
Why?
| | Female | 10 | 2017 | 73913 | 0.110 |
Why?
| | Nitrites | 1 | 2014 | 88 | 0.110 |
Why?
| | Endocarditis, Bacterial | 1 | 2014 | 45 | 0.110 |
Why?
| | Nitrates | 1 | 2014 | 94 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2015 | 10938 | 0.100 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2012 | 11 | 0.100 |
Why?
| | Goals | 1 | 2014 | 174 | 0.100 |
Why?
| | Adenosine Diphosphate | 1 | 2012 | 82 | 0.090 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 69 | 0.090 |
Why?
| | Arachidonic Acid | 1 | 2012 | 125 | 0.090 |
Why?
| | Platelet Aggregation | 1 | 2012 | 107 | 0.090 |
Why?
| | Heart Aneurysm | 1 | 2011 | 12 | 0.090 |
Why?
| | Monitoring, Intraoperative | 1 | 2011 | 60 | 0.090 |
Why?
| | Cytoskeleton | 1 | 2012 | 193 | 0.090 |
Why?
| | Hypotension | 1 | 2012 | 120 | 0.090 |
Why?
| | Prospective Studies | 2 | 2014 | 7639 | 0.090 |
Why?
| | Stroke Volume | 2 | 2015 | 579 | 0.080 |
Why?
| | ROC Curve | 1 | 2012 | 566 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1229 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 611 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 458 | 0.080 |
Why?
| | Coronary Artery Bypass | 1 | 2011 | 237 | 0.080 |
Why?
| | Reperfusion Injury | 1 | 2012 | 287 | 0.080 |
Why?
| | Nitric Oxide | 1 | 2014 | 894 | 0.080 |
Why?
| | Risk Factors | 3 | 2015 | 10398 | 0.080 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 365 | 0.080 |
Why?
| | Mass Spectrometry | 1 | 2012 | 741 | 0.080 |
Why?
| | Mitral Valve | 1 | 2009 | 96 | 0.070 |
Why?
| | Echocardiography, Doppler, Color | 1 | 2009 | 39 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2015 | 3581 | 0.070 |
Why?
| | Ventricular Function, Left | 1 | 2011 | 503 | 0.070 |
Why?
| | Image Enhancement | 1 | 2009 | 191 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1486 | 0.070 |
Why?
| | Heart Valve Diseases | 1 | 2009 | 152 | 0.070 |
Why?
| | Antifungal Agents | 1 | 2009 | 141 | 0.070 |
Why?
| | Phosphorylation | 1 | 2012 | 1770 | 0.070 |
Why?
| | Prosthesis Failure | 1 | 2009 | 124 | 0.070 |
Why?
| | Diagnosis, Differential | 1 | 2012 | 1496 | 0.070 |
Why?
| | Device Removal | 1 | 2009 | 136 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2055 | 0.070 |
Why?
| | Metabolomics | 1 | 2012 | 692 | 0.070 |
Why?
| | Adult | 4 | 2011 | 38296 | 0.060 |
Why?
| | Energy Metabolism | 1 | 2012 | 924 | 0.060 |
Why?
| | Cytokines | 1 | 2014 | 2084 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1326 | 0.060 |
Why?
| | Proteomics | 1 | 2012 | 1113 | 0.060 |
Why?
| | Time Factors | 2 | 2015 | 6877 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 4111 | 0.050 |
Why?
| | Enzyme Activation | 1 | 2017 | 819 | 0.030 |
Why?
| | Anaphylaxis | 1 | 2016 | 110 | 0.030 |
Why?
| | Retrospective Studies | 1 | 2011 | 15860 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 303 | 0.030 |
Why?
| | Vasodilation | 1 | 2016 | 511 | 0.020 |
Why?
| | Odds Ratio | 1 | 2015 | 1084 | 0.020 |
Why?
| | Syndrome | 1 | 2012 | 378 | 0.020 |
Why?
| | Portal Vein | 1 | 2012 | 119 | 0.020 |
Why?
| | End Stage Liver Disease | 1 | 2012 | 86 | 0.020 |
Why?
| | Ultrasonography | 1 | 2014 | 766 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2017 | 3038 | 0.020 |
Why?
| | Logistic Models | 1 | 2015 | 2088 | 0.020 |
Why?
| | Mice | 1 | 2017 | 17848 | 0.010 |
Why?
| | Animals | 1 | 2017 | 37309 | 0.010 |
Why?
|
|
Seres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|